N-Fluorobenzenesulfonimide → 3-chloro-N-[3-fluoro-6-methyl-2-(1H-pyrazol-4-yl)thieno[2,3-b]pyridin-4-yl]benzenesulfonamide
Reaction equation
Br[C:2]1[C:10]2[C:5](=[N:6][C:7]([CH3:22])=[CH:8][C:9]=2[NH:11][S:12]([C:15]2[CH:20]=[CH:19][CH:18]=[C:17]([Cl:21])[CH:16]=2)(=[O:14])=[O:13])[S:4][C:3]=1[C:23]1[CH:24]=[N:25][NH:26][CH:27]=1.[Li]CCCC.C1C=CC(S(N(S(C2C=CC=CC=2)(=O)=O)[F:43])(=O)=O)=CC=1>C1COCC1>[Cl:21][C:17]1[CH:16]=[C:15]([S:12]([NH:11][C:9]2[CH:8]=[C:7]([CH3:22])[N:6]=[C:5]3[S:4][C:3]([C:23]4[CH:24]=[N:25][NH:26][CH:27]=4)=[C:2]([F:43])[C:10]=23)(=[O:14])=[O:13])[CH:20]=[CH:19][CH:18]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- -78 °C
Procedure
A stirred solution of N-[3-bromo-6-methyl-2-(1H-pyrazol-4-yl)thieno[2,3-b]pyridin-4-yl]-3-chlorobenzenesulfonamide (Example 100) (120 mg, 0.248 mmol) in THF (1.5 mL) was cooled to −78° C. using a dry ice/acetone bath. n-BuLi (2.5M in Hexane) (0.109 mL, 0.273 mmol) was added dropwise and the mixture stirred at −78° C. for ca. 1.5 h. Then, N-fluorobenzenesulfonimide (82 mg, 0.260 mmol), pre-dissolved in THF (0.5 mL), was added dropwise and the mixture stirred at −78° C. for ca. 1 h and then left to stir at RT for 3 days (ca. 89 h). The reaction mixture was then quenched with saturated NH4Cl solution (ca. 20 mL), extracted with ethyl acetate (20 mL×3) and the combined organics dried and concentrated. The residue was purified by normal phase chromatography, eluting with a gradient of 0-100% ethyl acetate in DCM and further purified by MDAP (acidic conditions), to give the title compound (5 mg). LCMS (A) m/z: 423 [M+1]+, Rt 1.20 min (acidic).
Workup
- additionwas added dropwise
- stirringthe mixture stirred at −78° C. for ca. 1 h
- waitleft
- stirringto stir at RT for 3 days (ca. 89 h)
- customThe reaction mixture was then quenched with saturated NH4Cl solution (ca. 20 mL)
- extractionextracted with ethyl acetate (20 mL×3)
- customthe combined organics dried
- concentrationconcentrated
- customThe residue was purified by normal phase chromatography
- washeluting with a gradient of 0-100% ethyl acetate in DCM
- customfurther purified by MDAP (acidic conditions)
Sources & evidence
- ORD record
- ord-b7ea4b99ce8a49db85ce810c7bbe61c6
- Source dataset
- uspto-grants-2015_05
- Patent number
- US09029545B2
Reaction notes
Loading…